Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up1.00% Nasdaq Up1.29%

Alexza Pharmaceuticals Inc. (ALXA)

-NasdaqGM
4.10 Down 0.07(1.68%) 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 1,309   2,166   43,635   729  
Cost of Revenue4,297  3,951  2,961   -  
Gross Profit (2,988) (1,785) 40,674   729  
Operating Expenses
Research Development2,607  5,457  4,799  6,219  
Selling General and Administrative3,762  3,097  4,806  4,113  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (9,357) (10,339) 31,069   (9,603)
Income from Continuing Operations
Total Other Income/Expenses Net4,108  (1,612)(31,496)(10,887)
Earnings Before Interest And Taxes(5,249)(11,951)(427)(20,490)
Interest Expense443  461  372  222  
Income Before Tax(5,692)(12,412)(799)(20,712)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(5,692)(12,412)(799)(20,712)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (5,692) (12,412) (799) (20,712)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (5,692) (12,412) (799) (20,712)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.